Προς έγκριση 8 νέες θεραπείες στην Ε.Ε.

Προς έγκριση 8 νέες θεραπείες στην Ε.Ε.

European CHMP Adopts Positive Opinion on Ondexxya™ (andexanet alfa) Portola Pharmaceuticals’ Factor Xa Inhibitor Reversal Agent

European CHMP Adopts Positive Opinion on Ondexxya™ (andexanet alfa) Portola Pharmaceuticals’ Factor Xa Inhibitor Reversal Agent

10 Takeover Targets to Watch in 2019

0 Takeover Targets to Watch in 2019

Under The Radar Potential Small Cap Takeover Targets

Under The Radar Potential Small Cap Takeover Targets